4Kato H,Torigoe T. Radioimmunoassay for tumor antigen of human cervi-cal squamous cell cacinoma. Cancer, 1977 ;40 (4): 1621
5Takeshima-JH. The prognostic significance of pre and posttreatments SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy. Int-Radia-OnoolK-Biol-Phys, 1998 ;41 (4):823
6Pras E, Willemse PH, Canrinus AA, et al. Serum squarous cell caraino -ma antigen and CYFRA21-1 in cervical cancer treatment. Int J Radiat Oncol Biol Phys,2002;52( 1 ) :23
7Esajas MD,Duk JM,de Bruijn HW,et al. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer. J Clin Oncol,2001; 19 ( 19 ) :3960
8Chan YM, Ng TY, Ngan HY, et al. Monitoring of serum squamous cell carcinoma antigen levels in invasive cervical cancer: is it cost-effective? Gynecol 0ncol,2002 ;84( 1 ) :7
9Hong JH, Tsai CS, Chang JT, et al. The prognostic significance of pre- and post-treatment SCC levels in patients with squamous cell carcinoma of thecervix treated by radiotherapy. Int J Radiat Oncol Biol Phys, 1998 ;41 (4): 823
10De Bruijn HW, Duk JM, van der Zee AG, et al. The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix.Tumour Bio1,1998 ;19(6) :505
4Makhlpuf HR,Remotti HE,Ishak KG.Expression of KIT(CD117) in angimydipoma[J].Am J Surg Pathol,2002,26(4):493-497.
5Aoki D,Hirasawa A,Susumu N.Diagnostic significance of turner markers for gynecologic maligancies[J].Japanese Journal of Cancer and Chemotherapy,2005,32(3):411-416.
